Gyre Therapeutics, Inc. (GYRE)
8.02
+0.20
(+2.56%)
USD |
NASDAQ |
Feb 13, 16:00
8.03
+0.01
(+0.12%)
Pre-Market: 20:00
Gyre Therapeutics Price : 8.02 for Feb. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Marker Therapeutics, Inc. | 1.43 |
| Savara, Inc. | 5.60 |
| ADMA Biologics, Inc. | 16.09 |
| Viridian Therapeutics, Inc. | 27.90 |
| Nutex Health, Inc. | 99.71 |
Price Related Metrics
| PE Ratio | 211.05 |
| PS Ratio | 7.376 |
| Price to Book Value | 7.580 |
| Earnings Yield | 0.47% |
| Market Cap | 772.59M |
| Operating PE Ratio | 65.74 |
| Normalized PE Ratio | 405.05 |